RecruitingNASH - Nonalcoholic Steatohepatitis
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Eligible age
18–75 yrs
Accepts
All genders
Locations
6 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Sponsor: Perspectum
You may qualify if…
- ✓ Male and Female subjects aged between 18 and 75 years old
- ✓ Ability to understand and sign a written informed consent forms
- ✓ Patients scheduled to undergo a standard of care diagnostic liver biopsy as follows
- ✓ Percutaneous biopsy with a 16 gauged needle passed into the right lobe
- ✓ Trans-jugular biopsy with an 18 gauged needle passed into the right lobe
- ✓ Patients who are suspected of having NAFLD, who are being considered for treatment, and presenting with two or more of the following risk factors for NASH
- ✓ Elevated liver enzymes (ALT≥40)
- ✓ BMI≥25kG/m\^2
You may not qualify if…
- ✕ Prior histopathological diagnosis of NASH
- ✕ Inability to undergo a liver biopsy
- ✕ Prior or planned liver transplantation
- ✕ Patient scheduled to undergo a laparoscopic or wedge liver biopsy or biopsy taken from the left lobe
- ✕ Participation in an investigational new drug (IND) trial in the 30 days before enrolment
- ✕ Other known causes of chronic liver disease based on clinical criteria at the study site such as the following:
- ✕ Alcoholic liver disease
- ✕ Primary biliary cirrhosis
Where it's recruiting
Source: ClinicalTrials.gov · NCT04054310 · last updated 2026-05-19